These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11070635)

  • 1. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes.
    King RD; Gaines LS; Lambert EW; Summerfelt WT; Bickman L
    J Behav Health Serv Res; 2000 Nov; 27(4):417-30. PubMed ID: 11070635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
    Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of mental health services for persons with a dual diagnosis: a literature review and the CCMHCP. The Cost-Effectiveness of Community Mental Health Care for Single and Dually Diagnosed Project.
    Johnson J
    J Subst Abuse Treat; 2000 Mar; 18(2):119-27. PubMed ID: 10716095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Service costs of caring for adolescents with mental illness in a rural community, 1993-2000.
    Costello EJ; Copeland W; Cowell A; Keeler G
    Am J Psychiatry; 2007 Jan; 164(1):36-42. PubMed ID: 17202542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
    Havassy BE; Alvidrez J; Owen KK
    Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward cost-effective care for persons with dual diagnoses.
    Jerrell JM
    J Ment Health Adm; 1996; 23(3):329-37. PubMed ID: 10172689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of psychiatric comorbidity. Practical and theoretic considerations.
    Goldsmith RJ
    Psychiatr Clin North Am; 1999 Jun; 22(2):331-49, ix. PubMed ID: 10385937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual diagnosis and successful participation of adolescents in substance abuse treatment.
    Wise BK; Cuffe SP; Fischer T
    J Subst Abuse Treat; 2001 Oct; 21(3):161-5. PubMed ID: 11728790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.
    Brooner RK; King VL; Kidorf M; Schmidt CW; Bigelow GE
    Arch Gen Psychiatry; 1997 Jan; 54(1):71-80. PubMed ID: 9006403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social exclusion in clients with comorbid mental health and substance misuse problems.
    Todd J; Green G; Harrison M; Ikuesan BA; Self C; Pevalin DJ; Baldacchino A
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jul; 39(7):581-7. PubMed ID: 15243697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining dual diagnosis of mental illness and substance misuse: some methodological issues.
    Todd J; Green G; Harrison M; Ikuesan BA; Self C; Baldacchino A; Sherwood S
    J Psychiatr Ment Health Nurs; 2004 Feb; 11(1):48-54. PubMed ID: 14723639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with dual diagnosis in secondary psychiatric care.
    Luoto KE; Koivukangas A; Lassila A; Kampman O
    Nord J Psychiatry; 2016 Aug; 70(6):470-6. PubMed ID: 27049473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.